Contribution of endothelial injury and inflammation in early phase to vein graft failure: the causal factors impact on the development of intimal hyperplasia in murine models

PLoS One. 2014 Jun 2;9(6):e98904. doi: 10.1371/journal.pone.0098904. eCollection 2014.

Abstract

Objectives: Autologous veins are preferred conduits in by-pass surgery. However, long-term results are hampered by limited patency due to intimal hyperplasia. Although mechanisms involved in development of intimal hyperplasia have been established, the role of inflammatory processes is still unclear. Here, we studied leukocyte recruitment and intimal hyperplasia in inferior vena cava grafts transferred to abdominal aorta in mice.

Methods and results: Several microscopic techniques were used to study endothelium denudation and regeneration and leukocyte recruitment on endothelium. Scanning electron microscopy demonstrated denudation of vein graft endothelium 7 days post-transfer and complete endothelial regeneration by 28 days. Examination of vein grafts transferred to mice transgenic for green fluorescent protein under Tie2 promoter in endothelial cells showed regeneration of graft endothelium from the adjacent aorta. Intravital microscopy revealed recruitment of leukocytes in vein grafts at 7 days in wild type mice, which had tapered off by 28 days. At 28 and 63 days there was significant development of intimal hyperplasia. In contrast; no injury, leukocyte recruitment nor intimal hyperplasia occurred in arterial grafts. Leukocyte recruitment was reduced in vein grafts in mice deficient in E- and P-selectin. In parallel, intimal hyperplasia was reduced in vein grafts in mice deficient in E- and P-selectin and in wild type mice receiving P-selectin/E-selectin function-blocking antibodies.

Conclusion: The results show that early phase endothelial injury and inflammation are crucial processes in intimal hyperplasia in murine vein grafts. The data implicate endothelial selectins as targets for intervention of vein graft disease.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Disease Models, Animal
  • E-Selectin / genetics
  • Endothelium, Vascular / immunology
  • Endothelium, Vascular / injuries*
  • Graft Rejection / etiology*
  • Graft Rejection / immunology
  • Hyperplasia / etiology
  • Hyperplasia / immunology
  • Hyperplasia / pathology
  • Inflammation / immunology
  • Leukocytes / immunology
  • Mice
  • P-Selectin / genetics
  • Tunica Intima / immunology
  • Tunica Intima / pathology*
  • Veins / immunology
  • Veins / pathology
  • Veins / transplantation*

Substances

  • E-Selectin
  • P-Selectin

Grants and funding

This work was supported by the Swedish Heart-Lung Foundation (project number: 20060691, 20080365, 20080606 and 20090701), the Swedish Research Council (project number: K2009-65X-2233-01-3), and Karolinska Institutet. The sponsors had no role in the study design, data collection, data analysis, and interpretation of data. The sponsors were not involve in the writing of the manuscript or in the decision to submit the manuscript for publication.